Partner Headlines - CLVS

  1. Clovis Oncology Completes US, EU Regulatory Submissions for Rociletinib ...

    Benzinga
  2. Benzinga's Top Upgrades

    Benzinga
  3. Clovis Oncology Announces Exercise in Full of Underwriters' Option ...

    Benzinga
  4. Clovis Oncology Initiates Rolling NDA Submission to the FDA for ...

    Benzinga
  5. Morning Market Losers

    Benzinga
  6. J.P. Morgan's 3 Biotechnology Picks

    GuruFocus
  7. Clovis Technology Gets Big Boost From Goldman Upgrade

    IBD
  8. Benzinga's Volume Movers

    Benzinga
  9. Morning Market Gainers

    Benzinga
  10. Benzinga's Top Upgrades

    Benzinga
  11. Benzinga's Top #PreMarket Gainers

    Benzinga
  12. Goldman Sachs Upgrades Clovis Oncology To Buy

    Benzinga
  13. Earnings Scheduled For February 25, 2015

    Benzinga
  14. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  15. Morning Market Losers

    Benzinga
  16. Clovis Oncology Enters Into Oncology Clinical Trial Collaboration ...

    Benzinga
  17. UPDATE: Stifel Reiterates On Clovis Oncology Following 3Q14 LPS

    Benzinga
  18. Morning Market Losers

    Benzinga
  19. Biotech Enters Reporting Season With Large Caps Central To Sector ...

    Benzinga
  20. US Stock Futures Flat Ahead Of Manufacturing PMI

    Benzinga
  21. Market Wrap For June 5: Markets Positive Before Friday's Employment ...

    Benzinga
  22. UPDATE: Stifel Upgrades Clovis Oncology On Favorable Risk/Reward

    Benzinga
  23. Market Wrap For June 4: Markets Slightly Higher On Light Volume, ...

    Benzinga
  24. Citi Downgrades Clovis, Rates It As High Risk

    Benzinga
  25. Benzinga's Volume Movers

    Benzinga
  26. Benzinga's Top #PreMarket Gainers

    Benzinga
  27. UPDATE: Clovis Oncology Shares Rise 12% Premarket on Positive ...

    Benzinga
  28. US Stock Futures Rise; GDP, Jobless Claims Data In Focus

    Benzinga
  29. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues ...

    Benzinga
  30. Benzinga's Top Initiations

    Benzinga
  31. Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam ...

    Benzinga
  32. Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers ...

    Benzinga
  33. Benzinga's Top #PreMarket Gainers

    Benzinga
  34. Clovis Oncology Announces 2014 Objectives, Financial Guidance ...

    Benzinga
  35. What The Top Stocks Of 2013 Had In Common

    IBD
  36. Clovis Oncology CO-1686 Clinical Data Accepted as Oral Presentation ...

    Benzinga
  37. Clovis Oncology Announces 2M Share Offering by Selling Stockholders ...

    Benzinga
  38. Benzinga's M&A Chatter for Tuesday November 19, 2013

    Benzinga
  39. Why Clovis Oncology Was The Short Trade Of The Day

    Benzinga
  40. UPDATE: H.C. Wainwright nitiates on Clovis Oncology On Prospects ...

    Benzinga
  41. Mid-Morning Market Update: Markets Mixed; Merck Profit Beats ...

    Benzinga
  42. Clovis Oncology's CO-1686 Demonstrates Promising Clinical Activity ...

    Benzinga
  43. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  44. QIAGEN Announces Partnership With Clovis Oncology to Co-develop ...

    Benzinga
  45. Mid-Day Market Update: Dow Falls Over 100 Points; Active Network ...

    Benzinga
  46. Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net ...

    Benzinga
  47. Mid-Day Market Update: US Stocks Turn Higher; MAKO Surgical Shares ...

    Benzinga
  48. Mid-Morning Market Update: Markets Slip; AutoZone Q4 Net Profit ...

    Benzinga
  49. Morning Market Losers

    Benzinga
  50. Benzinga's M&A Chatter for Tuesday September 24, 2013

    Benzinga
  51. Benzinga's Top Initiations

    Benzinga
  52. Benzinga's M&A Chatter for Tuesday September 17, 2013

    Benzinga
  53. UPDATE: Stifel Initiates Coverage on Clovis Oncology, Awaiting ...

    Benzinga
  54. These ETFs House The Next Biotech Takeover Targets

    Benzinga
  55. Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes ...

    Benzinga
  56. Mid-Morning Market Update: Markets Continue Cautious Rally; Jefferies ...

    Benzinga
  57. Benzinga's Top Pre-Market Losers

    Benzinga
  58. Health Care Sector Wrap

    FoxBusiness
  59. Health Care Sector Wrap

    FoxBusiness
  60. Clovis Oncology and Array BioPharma Announce Agreement to Discover ...

    Benzinga
  61. Clovis Oncology Announces FDA Acceptance of Investigational New ...

    Benzinga
  62. End-of-Day Market Summary for January 18, 2012

    Benzinga
  63. UPDATE: JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  64. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  65. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!